Advertisement

Browse Subject Areas

?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Combined Targeting of BRAF and CRAF or BRAF and PI3K Effector Pathways Is Required for Efficacy in NRAS Mutant Tumors

Table 1

Cell cycle status after RAS, RAF, PI3KCA and MEK knockdown.

Table 1

doi: https://doi.org/10.1371/journal.pone.0005717.t001